Men’s average testosterone levels have halved in last 50 years, say scientists
By
Hannah Devlin Science correspondent
1h agoen
Source
The GuardianMen’s average testosterone levels have halved in last 50 years, say scientiststheguardian.comExclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes Men’s average testosterone levels have halved over the past 50 years, according to scientists, who say society is facing a male fertility crisis. Total testosterone levels in men declined by 54% between 1972 and 2019, according to data presented at the annual meeting of the European Society of Human Reproduction and Embryology in London on Tuesday. Continue reading...
You might also wanna read
New research shows men with very low testosterone levels are at higher risk of cancer later in life.
medicalxpress.com·5d ago
Large Analysis Links Low Testosterone to Higher Cancer Mortality Risk in Men
A large international analysis of 11 long-running studies involving over 26,000 men found that very low testosterone levels are associated w
Study Finds 88% of Testosterone Prescriptions Lack Required Diagnostic Testing
A single-center study presented in Chicago found that only 12% of men prescribed testosterone therapy received appropriate diagnostic testin
HHS seeks to ease testosterone therapy restrictions for older men, sparking debate among doctors
The Trump administration's HHS is requesting updates to prescribing information for testosterone replacement therapy (TRT), aiming to roll b
HHS seeks to ease testosterone therapy restrictions for older men, sparking debate among doctors
The Department of Health and Human Services (HHS) is requesting updates to prescribing information for testosterone replacement therapy (TRT
Study Finds Testosterone Administration Influences Political Preferences in Weakly Affiliated Democrats
A scientific study examined the effects of testosterone administration on political preferences in 136 healthy males. The research found tha

Comments
Sign in to join the conversation.
No comments yet. Be the first.